CA6 and acute myeloid leukemia: This study is aimed to investigate the expression status of the nine designated molecular markers including GGT5, FAM3A, PDCD7, FIS1, CA6, ATCAY, KLRF1, APP and Ang2, and their clinical relevance and prognostic significance in AML.